Stephen William Nelson

Stephen William Nelson discloses dealings in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) to SEDI. Over a trading history stretching from 16 October 2018 to 25 September 2025, the count stands at 13 filings.

Purchases make up the whole of the open-market record (2 purchases, €145k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 option exercises. 2025 to date brings 1 purchase and no sales.

The latest filing, published on 29 September 2025, reports an option exercise of €33k in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). The latest purchase dates back some time: it was published 429 days ago, on 21 August 2025. Filings reach the SEDI feed a median of 4 days after the trade. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.